
Cytokeratin 19 (Dako Omnis)

- Monoclonal Mouse Anti-Human
No data to display
This product is not available for purchase by the general public.
Product Details
Features
- Optimized staining performance of both high and low-expression structures
- Dako Omnis and the dynamic gap staining technology provides a consistent, uniform staining with excellent morphology
- Crisp and clear staining with no background
- Optimal laboratory efficiency with ready-to-use antibodies on Dako Omnis
- The staining performance of all FLEX RTU antibodies has been defined, tested and approved through collaboration with leading, international pathology experts.
Specifications
Application |
|
Clone |
|
Code Number |
|
Immunogen |
|
Isotype |
|
Reagent Provided |
|
Solutions |
|
Species |
|
Specificity |
|
Literature
- Catalogs
-
Atlas of Controls
The Atlas of Controls illustrates the staining performance of each antibody in the FLEX Ready-to-Use system.
- Catalogs
- English
- 26 Mar 2024
- 37.78 MB
- Technical Overviews
Support
- Instructions for Use
-
Featured References
- Product Description References
-
1. Dalal P, Shousha S. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions. Mod Pathol 1995,8:413-6.
Promotions